🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ascites is a cardinal and debilitating complication in patients with acute-...
Status
Not Yet Recruiting
Location
Institute of Liver and Biliary Sciences
Start Date
2026-02-05
Trial ID
NCT07422948
Treatments Being Tested
Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersi...
Status
Completed
Location
Bausch Health Site 18
Start Date
2018-09-13
Trial ID
NCT03515044
Irritable bowel syndrome (IBS) is one of the most common gastrointestinal d...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2018-07-01
Trial ID
NCT03462966
Treatments Being Tested
This study is for patients with cirrhosis and hepatic encephalopathy who ar...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11
Trial ID
NCT04128462
Treatments Being Tested
Refractory ascites is seen in 5-10% of patients with cirrhosis.Decompensate...
Status
Unknown
Location
Multiple Locations
Start Date
2020-11
Trial ID
NCT04621617
Treatments Being Tested
Cirrhosis of liver is a leading cause of morbidity and mortality worldwide....
Status
Unknown
Location
Post Graduate Institute of Medical Education and Research
Start Date
2019-05-04
Trial ID
NCT03911037
Earlier protein restriction was advocated in the treatment of HE but later ...
Status
Unknown
Location
Sir Ganga Ram Hospital
Start Date
2024-02-16
Trial ID
NCT06328088
Treatments Being Tested
In patients with cirrhosis and healthy controls to determine the utility of...
Status
Completed
Location
Hunter Holmes McGuire VA Medical Center
Start Date
2022-10-28
Trial ID
NCT05604274
Treatments Being Tested
The study will be double blind with respect to rifaximin, and randomization...
Status
Completed
Location
Institute of Liver & Biliary Sciences (ILBS)
Start Date
2010-10
Trial ID
NCT01218568
Treatments Being Tested
The purpose of this study is to determine whether taking Rifaximin (Xifaxan...
Status
Terminated
Location
Tampa General Medical Group
Start Date
2013-04
Trial ID
NCT01842113
Treatments Being Tested